Volume 21 Number 10

In this 20th anniversary EuroPCR edition of EuroIntervention, we bring you a State-of-the-Art on the treatment of patent foramen ovale and an expert review on contemporary techniques for leaflet modification to prevent coronary obstruction during transcatheter aortic valve interventions. In original research: new data are presented on long-term structural valve deterioration after TAVI; an analysis of ticagrelor monotherapy vs ticagrelor-based standard DAPT in CCS patients from the TWILIGHT trial; the POMPEII Registry’s study on cangrelor in both acute and chronic coronary syndrome; and the design and rationale of the COMPARE STEMI ONE trial evaluating the non-inferiority of an abbreviated DAPT regimen of 1 month followed by prasugrel monotherapy in STEMI patients undergoing PCI. A research correspondence on OCT versus IVUS in patients with and without ACS. A viewpoint from the PCR Board on the future of Europe’s medical device industry and another on unblinded trials and subjective endpoints; flashlights; news from the EAPCI; and more...

In this issue of EuroIntervention

Our 20th anniversary EuroPCR edition with a State-of-the-Art on the treatment of patent foramen ovale; an expert review of leaflet modification techniques during TAVI; long-term structural valve deterioration after TAVI; ticagrelor monotherapy; cangrelor in acute and chronic coronary syndromes; rationale and design of the COMPARE STEMI ONE trial; OCT versus IVUS in patients with and without acute coronary syndromes; and more

Capodanno D

free

Viewpoint

Restoring Europe's global position in medical device innovation

Gilard M, Prendergast B, Wijns W, Baumbach A, Maisano F, of the PCR Board o

10.4244/EIJ-E-25-00017

Unblinded trials of transcatheter interventions with subjective endpoints: what are the implications?

Kaul S

10.4244/EIJ-D-24-01198

State-of-the-Art

Treatment of patent foramen ovale

Pristipino C, Carroll J, Mas J, Wunderlich N, Søndergaard L

10.4244/EIJ-D-23-00915

Expert Review

Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation

Goel S, Tanner R, Chan K, Khan J, Vinayak M, Lerakis S, Safi L, Khera S, Krishnamoorthy P, Kini A, Sharma S, Dangas G, Tang G

10.4244/EIJ-D-24-00972

Original Research

Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI Registry

Giannini C, Capodanno D, Toth G, Windecker S, Schüpke S, Blackman D, Noble S, Eltchaninoff H, Fiorina C, Chieffo A, Bartorelli A, Schmidt A, De Backer O, Gilard M, Curtis E, L’Official G, Donal E, Laroche C, Prendergast B, Petronio A, the European Valve Durability TAVI Registry investigators o

10.4244/EIJ-D-24-00662

Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial

Gitto M, Baber U, Sartori S, Vogel B, Angiolillo D, Briguori C, Cohen D, Collier T, Dudek D, Oliva A, Escaned J, Feng Y, Gibson C, Han Y, Di Muro F, Shlofmitz R, Huber K, Steg P, Sharma S, Sardella G, Kastrati A, Kaul U, Kornowski R, Kunadian V, Stefanini G, Mehta S, Dangas G, Mehran R

10.4244/EIJ-D-24-00973

Editorial comment

Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome

Watanabe H, Kimura T

10.4244/EIJ-E-25-00015

free

Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry

Gargiulo G, Cirillo P, Sperandeo L, Castiello D, Manzi L, Forzano I, Florimonte D, Simonetti F, Canonico M, Avvedimento M, Paolillo R, Spinelli A, Buongiorno F, Serafino L, Spaccarotella CAM, Franzone A, Piccolo R, Stabile E, Valgimigli M, Esposito G

10.4244/EIJ-D-24-00757

Editorial comment

Platelet reactivity when switching from cangrelor to oral P2Y12 receptor inhibitors: insights from a real-world registry

Franchi F, Laudani C

10.4244/EIJ-E-25-00008

free

Trial Design

Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial

Paradies V, Van Mieghem N, Oemrawsingh R, Richardt G, Esposito G, Campo G, Burzotta F, Canova P, Linke A, Porto I, Trabattoni D, Teeuwen K, Adriaenssens T, Kala P, Stankovic G, Vliet R, Giacoppo D, Daemen J, Smits P

10.4244/EIJ-D-24-00829

Research Correspondence

Optical coherence tomography versus intravascular ultrasound- guided PCI in patients with and without acute coronary syndrome: a prespecified subanalysis of the OCTIVUS trial

Kim J, Hong S, Lim S, Cha J, Joo H, Park J, Yu C, Lim D, Kang D, Ahn J, Park D, Park S

10.4244/EIJ-D-24-00911

Flashlight

Transcaval access with an IVUS-assisted aorta-outward puncture

Muñoz Bravo J, Aguasca G, Goena A, García V, Monastyrski A, Gotarda N, Irurueta I, Creus B, Pujol Y, del Blanco B

10.4244/EIJ-D-24-00429

EAPCI Column

EAPCI at EuroPCR 2025

free